We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Democratic presidential hopeful Pete Buttigieg unveiled a drug pricing proposal on Monday that’s not just a cut-and-paste of the bill recently announced by his party colleagues in Congress. Read More
Nevada’s Department of Health and Human Services sent penalty letters last week to 21 drugmakers — totaling $17.4 million — for failing to file pricing reports on their diabetes drugs. Read More
Attorneys general from than two dozen states pushed back against Purdue Pharma’s plan to pay employees $38 million in bonuses, in a joint filing with the U.S. Bankruptcy Court in the Southern District of New York. Read More
A report from the White House Council of Economic Advisors on measuring prescription drug prices finds that the CPI Prescription Drug Index (CPI-Rx) prepared by the Bureau of Labor Statistics is “the best available summary measure” of the prescription drug price changes — but some groups claim it’s flawed because it leaves out new, expensive drugs. Read More
In an usual move, the Institute for Clinical and Economic Review (ICER) quickly withdrew a draft report that questioned the cost-effectiveness of three rheumatoid arthritis treatments, saying that it needs to reconsider its approach. Read More
President Trump hinted that a drug importation proposal is coming soon from HHS, during a Thursday speech on an executive order aimed at improving Medicare. Read More